Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma

Marlene Hennessy, Andrew Wahba, Kumar Felix, Mariella Cabrera, Maria Gabriela Segura, Vikas Kundra, Murali K. Ravoori, John Stewart, Eugenie S. Kleinerman, Vanessa Behrana Jensen, Vidya Gopalakrishnan, Rhoneil Pena, Phi Quach, Grace Kim, Saul Kivimäe, Loui Madakamutil, Willem W. Overwijk, Jonathan Zalevsky, Nancy Gordon

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences